Evidence map›Paper›PMID 27899577›Full record

ArticleNucleic acids research2017

A comprehensive approach to expression of L1 loci.

Prescott Deininger, Maria E Morales, Travis B White, Melody Baddoo, Dale J Hedges, Geraldine Servant, Sudesh Srivastav, Madison E Smither, Monica Concha, Dawn L DeHaro and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Regulation and function of transposable elements in cancer genomes.Cellular and molecular life sciences : CMLS · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Prescott DeiningerTulane Cancer Center, Tulane University, New Orleans, LA 70112, USA.
Maria E MoralesTulane Cancer Center, Tulane University, New Orleans, LA 70112, USA.
Travis B WhiteTulane Cancer Center, Tulane University, New Orleans, LA 70112, USA.
Melody BaddooTulane Cancer Center, Tulane University, New Orleans, LA 70112, USA.
Dale J HedgesTulane Cancer Center, Tulane University, New Orleans, LA 70112, USA.
Geraldine ServantTulane Cancer Center, Tulane University, New Orleans, LA 70112, USA.
Sudesh SrivastavDepartment of Structural and Cellular Biology, Tulane University, New Orleans, LA 70112, USA.
Madison E SmitherTulane Cancer Center, Tulane University, New Orleans, LA 70112, USA.
Monica ConchaTulane Cancer Center, Tulane University, New Orleans, LA 70112, USA.
Dawn L DeHaroTulane Cancer Center, Tulane University, New Orleans, LA 70112, USA.
Erik K FlemingtonTulane Cancer Center, Tulane University, New Orleans, LA 70112, USA.
Victoria P BelancioTulane Cancer Center, Tulane University, New Orleans, LA 70112, USA.
Tulane University · US

Funding

"Project 3" MHV68 IncRNA/miRNA interaction in latency and lympomagenesisP01CA214091 · NCI · UNIVERSITY OF FLORIDA · PI ERIK K FLEMINGTON · 2017 to 2026
$15.9M
Mentoring a Cancer Genetics ProgramP20GM103518 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI DEININGER, PRESCOTT L. · 2012 to 2013
$4.3M
Epstein Barr virus antisense transcriptionR01AI106676 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2014 to 2018
$1.9M
Intercellular communication in Epstein Barr virus reactivationR01AI101046 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2012 to 2016
$1.9M
NCI NIH HHS P01 CA214091NIAID NIH HHS R01 AI101046NIAID NIH HHS R01 AI106676NIGMS NIH HHS P20 GM103518
6 · The paper itself

Abstract

L1 elements represent the only currently active, autonomous retrotransposon in the human genome, and they make major contributions to human genetic instability. The vast majority of the 500 000 L1 elements in the genome are defective, and only a relatively few can contribute to the retrotransposition process. However, there is currently no comprehensive approach to identify the specific loci that are actively transcribed separate from the excess of L1-related sequences that are co-transcribed within genes. We have developed RNA-Seq procedures, as well as a 1200 bp 5΄ RACE product coupled with PACBio sequencing that can identify the specific L1 loci that contribute most of the L1-related RNA reads. At least 99% of L1-related sequences found in RNA do not arise from the L1 promoter, instead representing pieces of L1 incorporated in other cellular RNAs. In any given cell type a relatively few active L1 loci contribute to the 'authentic' L1 transcripts that arise from the L1 promoter, with significantly different loci seen expressed in different tissues.

Indexed as

Genetic LociGenome, HumanLong Interspersed Nucleotide ElementsTranscription, GeneticAnimalsChromosome MappingChromosomes, HumanDNA, ComplementaryGenomic InstabilityHeLa CellsHumansMiceNIH 3T3 CellsNucleic Acid Amplification TechniquesPromoter Regions, GeneticRNA, MessengerDNA, ComplementaryRNA, Messenger

Identifiers

PMID27899577
PMCPMC5389711
OpenAlexW2557584271

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.